This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aucentra Holdings Pty Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Stephen Philip
Introduction
Stephen Philip is an accomplished inventor based in Elizabeth South, Australia. He has made significant contributions to the field of therapeutic agents, particularly in the development of inhibitors for protein kinases. His work is particularly relevant in the treatment of various proliferative cell diseases, including cancers.
Latest Patents
Stephen Philip holds a patent for a novel class of inhibitors known as 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives. This patent focuses on their utility as therapeutic agents in treating conditions characterized by over-expression of CDK8 and aberrant CDK8 activity. The inhibitors are particularly useful in addressing cancers of the lung, breast, brain, ovary, prostate, colorectal cancer, and leukaemias. He has 1 patent to his name.
Career Highlights
Stephen is associated with Aucentra Holdings Pty Ltd, where he continues to innovate and develop new therapeutic solutions. His work has the potential to impact the lives of many patients suffering from serious health conditions.
Collaborations
Stephen collaborates with notable colleagues, including Shudong Wang and Mingfeng Yu, who contribute to his research and development efforts.
Conclusion
Stephen Philip's innovative work in the field of therapeutic agents showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer and other proliferative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile